FY09 is going to be a great year for NMS; they're off to a great start already and we can expect a lot more announcements like todays. It's a pity it wasn't announced on a better market
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%